Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...

While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health ...

One of the world’s largest studies of Ozempic, Mounjaro and other blockbuster diabetes and obesity drugs highlighted their impact on the brain, pointing to benefits from addiction to schizophrenia.

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

An international commission made the case for focusing on body fat quantity and the illnesses people experience.

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties.

The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...

Can weight loss drugs curb alcohol addictions? This Louisiana doctor is keeping an eye on new findings and emerging research.